Combining cost and benefits of treatment.
The cost-effectiveness analysis (CEA) offers the possibility of comparing measurable clinical outcomes with the associated costs. The results are presented in price per unit for medical parameters (surrogate parameters or a patient-relevant endpoint). The CEA allows a comparison between two or more different effective interventions. As a result, the additional costs can be compared with additionally gained effectiveness (so-called, „incremental cost-effectiveness ratio“, [ICER]). The most commonly used result parameters are cost per life-year gained or quality-adjusted life-years.